Your browser doesn't support javascript.
loading
Raddeanin A Protects the BRB Through Inhibiting Inflammation and Apoptosis in the Retina of Alzheimer's Disease.
Wang, Xiao-Fang; Xiang, Xiao-Hong; Wei, Jing; Zhang, Peng-Bo; Xu, Qin; Liu, Meng-Han; Qu, Li-Qun; Wang, Xing-Xia; Yu, Lu; Wu, An-Guo; Qing, Da-Lian; Wu, Jian-Ming; Law, Betty Yuen-Kwan; Yu, Chong-Lin.
Afiliación
  • Wang XF; Laboratory Animal Centre, Model Animal and Human Disease Research of Luzhou Key Laboratory, Southwest Medical University, Luzhou, China.
  • Xiang XH; School of Basic Medical Sciences of Southwest Medical University, Luzhou, China.
  • Wei J; Department of Ophthalmology in The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Zhang PB; Eye School and Key Laboratory of Sichuan Province Ophthalmopathy Prevention & Cure and Visual Function Protection of Chengdu University of TCM, Chengdu, China.
  • Xu Q; Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 15651, China.
  • Liu MH; Department of Ophthalmology in The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Qu LQ; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine and Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China.
  • Wang XX; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine and Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China.
  • Yu L; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine and Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China.
  • Wu AG; Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica of Southwest Medical University, Luzhou, 646000, China.
  • Qing DL; Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica of Southwest Medical University, Luzhou, 646000, China.
  • Wu JM; Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica of Southwest Medical University, Luzhou, 646000, China.
  • Law BY; School of Basic Medical Sciences of Southwest Medical University, Luzhou, China.
  • Yu CL; Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica of Southwest Medical University, Luzhou, 646000, China.
  • Yong-Tang; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine and Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China. yklaw@must.edu.mo.
Neurochem Res ; 49(8): 2197-2214, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38834846
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Retina / Ratones Transgénicos / Barrera Hematorretinal / Apoptosis / Enfermedad de Alzheimer Límite: Animals / Humans / Male Idioma: En Revista: Neurochem Res Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Retina / Ratones Transgénicos / Barrera Hematorretinal / Apoptosis / Enfermedad de Alzheimer Límite: Animals / Humans / Male Idioma: En Revista: Neurochem Res Año: 2024 Tipo del documento: Article País de afiliación: China